TLDR Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.
The document from 2016 addresses the management of dyslipidemia in women, with a focus on pregnancy, polycystic ovarian syndrome (PCOS), and menopause. It recommends screening for dyslipidemia before or early in pregnancy and managing it with diet, exercise, and glycemic control, noting that lipid levels naturally increase during pregnancy and levels above 250 mg/dL may indicate complications. For women with PCOS, it discusses the risks associated with combined oral contraceptives and the impact of insulin resistance on lipid levels. The document also covers menopausal hormone therapy (HT), advising against its use for cardiovascular purposes due to thrombotic risks and suggesting an individualized approach to treatment. It mentions that transdermal HT may have a lower risk of thromboembolism and stroke, but more evidence is needed. Overall, the document emphasizes the importance of lipid management in women's health and the need for careful consideration of treatment options in relation to reproductive status and cardiovascular risk.
92 citations,
May 2014 in “The American Journal of Medicine” The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.
1265 citations,
October 2013 in “The Journal of Clinical Endocrinology and Metabolism” The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.
815 citations,
April 2010 in “The Journal of Clinical Endocrinology & Metabolism” Women with PCOS should be screened for heart disease risk and manage their health to prevent it.
31 citations,
May 2012 in “European Journal of Dermatology” Menopause affects hair and skin; more research needed for treatment.
9 citations,
May 2015 in “Cardiology Clinics” The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.
12 citations,
March 2017 in “Journal of obstetrics and gynaecology Canada” Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.
February 2024 in “Endocrinology and Disorders” Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.
10 citations,
January 2019 in “Archives of Endocrinology and Metabolism” Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.
